B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520)

PRESS RELEASE

published on 10/31/2024 at 19:20, 1 year 4 months ago

BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E(R) CRISPR-Cas technology, offering up to EUR 92.3 million R&D and commercial milestone fees along with royalties

BRAIN Biotech AG CRISPR-Cas Technology Pharma Licensing Agreement Akribion Therapeutics GmbH G-dase E(R)
BRIEF

published on 10/31/2024 at 19:16, 1 year 4 months ago

BRAIN Biotech AG Secures Licensing Deal with Akribion Therapeutics

Royalties Biotech Licensing CRISPR-Cas Technology Pharma Agreement Milestone Fees
BRIEF

published on 10/31/2024 at 19:16, 1 year 4 months ago

BRAIN Biotech AG conclut un accord de licence avec Akribion Therapeutics

Redevance Licences Biotechnologiques Technologie CRISPR-Cas Accord Pharmaceutique Frais D'étape
PRESS RELEASE

published on 10/31/2024 at 19:11, 1 year 4 months ago

EQS-Adhoc: BRAIN Biotech AG signs exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology with Akribion Therapeutics GmbH for up to EUR 92.3 million milestone fees plus royalties
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E® CRISPR-Cas technology, potentially receiving up to EUR 92.3 million milestone fees and royalties

BRAIN Biotech AG CRISPR-Cas Technology Pharma Licensing Agreement Akribion Therapeutics GmbH G-dase E®
BRIEF

published on 10/03/2024 at 14:05, 1 year 5 months ago

Prof. Dr. Wiltrud Treffenfeldt Steps Down from BRAIN Biotech AG Supervisory Board

Biotechnology Resignation Supervisory Board BRAIN Biotech AG Wiltrud Treffenfeldt
BRIEF

published on 10/03/2024 at 14:05, 1 year 5 months ago

Le professeur Wiltrud Treffenfeldt quitte le conseil de surveillance de BRAIN Biotech AG

Biotechnologie Démission Conseil De Surveillance BRAIN Biotech SA Wiltrud Treffenfeldt
PRESS RELEASE

published on 10/03/2024 at 14:00, 1 year 5 months ago

Prof. Dr. Wiltrud Treffenfeldt leaves Supervisory Board of BRAIN Biotech AG for personal reasons
Prof. Dr. Wiltrud Treffenfeldt resigns from Supervisory Board of BRAIN Biotech AG for personal reasons. Search for successor initiated. Company specializes in industrial biotechnology solutions

Biotechnology Resignation Supervisory Board Successor BRAIN Biotech AG
BRIEF

published on 09/20/2024 at 19:55, 1 year 6 months ago

BRAIN Biotech AG Secures EUR 128.88 Million Deal with Royalty Pharma

Non-dilutive Financing BRAIN Biotech AG Royalty Monetization Investigational Compound Industrial Enzymes
BRIEF

published on 09/20/2024 at 19:55, 1 year 6 months ago

BRAIN Biotech AG conclut un accord de 128,88 millions d'euros avec Royalty Pharma

BRAIN Biotech SA Financement Non Dilutif Monétisation Des Redevances Composé Expérimental Enzymes Industrielles
BRIEF

published on 09/20/2024 at 19:52, 1 year 6 months ago

BRAIN Biotech AG Secures Royalty Monetization Deal Worth Up to EUR 128.88 Million

BRAIN Biotech Royalty Monetization Deucrictibant Royalty Pharma Hereditary Angioedema

Published on 03/30/2026 at 08:00, 33 minutes ago

Portfolio Update
Published on 03/30/2026 at 08:00, 33 minutes ago

Touchstone Exploration Announces an Operational Update
Published on 03/30/2026 at 00:15, 8 hours 18 minutes ago

$520,000 Cash R&D Tax Refund Received
Published on 03/29/2026 at 12:15, 20 hours 18 minutes ago

China Xlx Announces 2025 Annual Results Deepening Efforts in Reducing Costs, Enhancing Efficiency, Strengthening Competitiveness Through Differentiation and Driving Marketing Transformation
Published on 03/28/2026 at 01:00, 2 days 7 hours ago

Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering

View all ACCESSWIRE

Published on 03/30/2026 at 08:00, 33 minutes ago

MHM Corporate: AGO 27.03.26 - CP résultats
Published on 03/30/2026 at 08:00, 33 minutes ago

MHM Corporate: AGO 27.03.26 - results
Published on 03/30/2026 at 08:00, 33 minutes ago

Transaction in Own Shares
Published on 03/30/2026 at 08:00, 33 minutes ago

Annual Financial Report
Published on 03/30/2026 at 08:00, 33 minutes ago

Fuller, Smith & Turner PLC: Directorate Changes

View all EQS

Published on 03/28/2026 at 07:00, 2 days 1 hour ago

Groupe DLSI - Résultat 2025
Published on 03/27/2026 at 19:06, 2 days 13 hours ago

Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 19:06, 2 days 13 hours ago

Mersen: Disclosure of trading own shares
Published on 03/27/2026 at 18:52, 2 days 13 hours ago

Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 2 days 13 hours ago

Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025

View all LES ECHOS COMFI WIRE

News